Cetera Trust Company’s Quest Diagnostics DGX Stock Holding History

Cetera Trust Company’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.36K	Hold	30	–	–	﹤0.01%	324
2026 Q1	$5.88K	Hold	30	–	–	﹤0.01%	330
2025 Q4	$5.21K	Hold	30	–	–	﹤0.01%	338
2025 Q3	$5.72K	Hold	30	–	–	﹤0.01%	330
2025 Q2	$5.39K	Hold	30	–	–	﹤0.01%	336
2025 Q1	$5.08K	Hold	30	–	–	﹤0.01%	345
2024 Q4	$4.53K	Hold	30	–	–	﹤0.01%	366
2024 Q3	$4.66K	Hold	30	–	–	﹤0.01%	374
2024 Q2	$4.11K	Hold	30	–	–	﹤0.01%	381
2024 Q1	$3.99K	Hold	30	–	–	﹤0.01%	392
2023 Q4	$4.14K	Buy	+30	New	+$3.94K	﹤0.01%	382

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Cetera Trust Company's DGX Position: Q2 2026 in Review

Cetera Trust Company held its Quest Diagnostics (DGX) position steady in Q2 2026 at 30 shares worth $6.36K. The position accounts for ﹤0.01% of the portfolio, ranked #324.

Cetera Trust Company first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Cetera Trust Company held 30 shares of Quest Diagnostics worth $6.36K as of Q2 2026.
Cetera Trust Company left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Cetera Trust Company's portfolio in Q2 2026, its #324 holding.
Cetera Trust Company first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.